Welcome to INNOQUA web site
Innoqua Toxicology Consultants, S.L. (Innoqua) is a consultancy organization based in Barcelona and Madrid (Spain). Founded in 2004, Innoqua is made up of a team of professionals with significant combined experience in toxicology, safety assessment, regulatory framework and project management skills. Innoqua provides assistance to third party companies in a wide range of activities related with preclinical development.
An increasing number of companies in Pharmaceutical and Biotechnology industries put their drug substances and products into our hands to deal with the nonclinical development from selection of drug candidate through to clinical phase approval in Europe and US. Innoqua helps with the design of tailored nonclinical programs, interpretation of toxicological issues, preparation of regulatory dossiers, regulatory scientific advice procedures, direct management and monitoring of toxicology studies, and assessment on critical safety issues of the drug products.
Our experience is backed up by our direct involvement in more than 500 nonclinical studies, 40 nonclinical programs of new chemical entities as well as drug repositioning. Among them, 16 projects are already in clinical phases I and II in Europe and the US, and have reached satisfactory full compliance from EMA, FDA and local agencies. We have experience in many routes of administration including oral, dermal, intravenous infusion and inhalation; and therapeutic areas such as cancer, diabetes and metabolic diseases, Parkinson’s disease and other neurodegenerative diseases, pain, hypertension, immunomodulators, vaccines, orphan diseases, etc.
Innoqua also provides assistance in the safety assessment and execution of toxicological studies required for Medical devices to be placed on the market. Likewise, our experts help our clients to assess the safety of new Cosmetic ingredients and products, being certified to make safety assessment reports in accordance with the new European Cosmetics regulation requirements.
INNOQUA can also offer safety evaluation and monitoring of toxicological studies on veterinary medicines, agro-chemical products and food additives in accordance with their respective regulations.
We naturally make sure that all the nonclinical safety studies performed for our customers are fully compliant with the Good Laboratory Practice regulations (GLP) as required.
We invite you to look further into our services to find out how our expertise, commitment and flexibility can contribute to make safer drugs and chemicals and help your company to simplify the long process to assess the safety of your products and meet regulatory milestones in a timely, smooth and cost-efficient way.
An increasing number of companies in Pharmaceutical and Biotechnology industries put their drug substances and products into our hands to deal with the nonclinical development from selection of drug candidate through to clinical phase approval in Europe and US. Innoqua helps with the design of tailored nonclinical programs, interpretation of toxicological issues, preparation of regulatory dossiers, regulatory scientific advice procedures, direct management and monitoring of toxicology studies, and assessment on critical safety issues of the drug products.
Our experience is backed up by our direct involvement in more than 500 nonclinical studies, 40 nonclinical programs of new chemical entities as well as drug repositioning. Among them, 16 projects are already in clinical phases I and II in Europe and the US, and have reached satisfactory full compliance from EMA, FDA and local agencies. We have experience in many routes of administration including oral, dermal, intravenous infusion and inhalation; and therapeutic areas such as cancer, diabetes and metabolic diseases, Parkinson’s disease and other neurodegenerative diseases, pain, hypertension, immunomodulators, vaccines, orphan diseases, etc.
Innoqua also provides assistance in the safety assessment and execution of toxicological studies required for Medical devices to be placed on the market. Likewise, our experts help our clients to assess the safety of new Cosmetic ingredients and products, being certified to make safety assessment reports in accordance with the new European Cosmetics regulation requirements.
INNOQUA can also offer safety evaluation and monitoring of toxicological studies on veterinary medicines, agro-chemical products and food additives in accordance with their respective regulations.
We naturally make sure that all the nonclinical safety studies performed for our customers are fully compliant with the Good Laboratory Practice regulations (GLP) as required.
We invite you to look further into our services to find out how our expertise, commitment and flexibility can contribute to make safer drugs and chemicals and help your company to simplify the long process to assess the safety of your products and meet regulatory milestones in a timely, smooth and cost-efficient way.
